Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Indian J Med Microbiol ; 2022 Sep 26.
Article in English | MEDLINE | ID: covidwho-2280744

ABSTRACT

64 years old male presented fever, gastrointestinal symptoms, COVID-19 infection with bioprosthetic mitral in situ, cardio embolic stroke 2 years ago. The 2 D ECHO showed a vegetation indicating infective endocarditis. Three paired blood cultures grew Kytococcus schroeteri. The organism was sensitive to Vancomycin, Teicoplanin, Gentamycin and Linezolid. Patient had multiorgan dysfunction which further deteriorated into failure, disseminated intravascular coagulation resulting into death of the patient.

2.
Indian J Med Microbiol ; 40(3): 462-464, 2022.
Article in English | MEDLINE | ID: covidwho-1821285

ABSTRACT

A 68-year-old female patient who was treated with anti-viral, steroids and biologics for coronavirus disease- 19 (COVID- 19) infection presented to our facility following right abdominal and flank pain since a week. Initially attributed to pancreatitis and right sided pyelonephritis, it was diagnosed as mucormycosis on KOH mount following CT-guided renal biopsy. She underwent right total nephrectomy and Whipple's surgery followed by Isavuconazole and liposomal Amphotericin B. This is a rare presentation of renal and gastrointestinal mucormycosis in a patient without diabetes mellitus following COVID- 19 infection. High suspicion and early diagnosis help in timely treatment of this life-threatening infection.


Subject(s)
COVID-19 , Coronavirus , Mucormycosis , Aged , Antifungal Agents/therapeutic use , COVID-19/complications , Female , Humans , Kidney , Mucormycosis/diagnosis , Mucormycosis/drug therapy , Mucormycosis/pathology
4.
Indian J Med Microbiol ; 39(1): 116-117, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1091812

ABSTRACT

There are several reports of Ct values of RT PCR assays for COVID 19 being associated with disease severity and infectivity. We studied the correlation between Ct values and disease severity and mortality at our hospital . All patients with RT PCR diagnosed COVID 19 illness admitted at the study site and for whom Ct values were available were included in the study. The patients with mild disease had significantly lower Ct values than patients with severe disease but had also been tested significantly earlier in the illness than those with severe disease. The patients who died had significantly lower Ct values than patients who survived but here again they had significantly shorter duration of symptoms before testing. We therefore recommend that the time of testing since onset of symptoms should be controlled for while correlating Ct values with disease severity.


Subject(s)
COVID-19/mortality , COVID-19/virology , SARS-CoV-2 , COVID-19/diagnosis , COVID-19/epidemiology , Female , Humans , Male , Mortality , Reverse Transcriptase Polymerase Chain Reaction/methods , SARS-CoV-2/classification , SARS-CoV-2/genetics , Severity of Illness Index
5.
Indian J Med Microbiol ; 39(3): 320-322, 2021 07.
Article in English | MEDLINE | ID: covidwho-1091810

ABSTRACT

A 52 year old previously healthy woman from Mumbai presented with fever and jaundice of 10 days duration. At admission, she was jaundiced with tachycardia, tachypnea, hypoxia, hypotension, conjunctival congestion and mild erythematous flush over the skin. She had very high WBC counts and CRP's with direct hyperbilirubinemia and azotemia. Investigations for infectious causes of fever were negative. RT-PCR for SARS-CoV-2 in the nasopharynx was negative. However her SARS-CoV-2 antibodies were reactive. She also had echocardiographic and biochemical evidence of cardiac dysfunction. The diagnosis of Multisystem inflammatory syndrome-Adult (MIS-A) was thus established. She rapidly improved with intravenous immunoglobulin (2 gm/kg) and high dose steroids.


Subject(s)
Fever/etiology , Jaundice/etiology , Azotemia/drug therapy , Azotemia/metabolism , Azotemia/microbiology , COVID-19/microbiology , Echocardiography , Fever/drug therapy , Fever/metabolism , Humans , Hyperbilirubinemia/drug therapy , Hyperbilirubinemia/metabolism , Hyperbilirubinemia/microbiology , Immunoglobulins/therapeutic use , Jaundice/drug therapy , Jaundice/metabolism , Reverse Transcriptase Polymerase Chain Reaction , SARS-CoV-2/drug effects , SARS-CoV-2/pathogenicity , Steroids/metabolism
6.
Int J Environ Res Public Health ; 17(19)2020 09 25.
Article in English | MEDLINE | ID: covidwho-1006180

ABSTRACT

In Kenya, millions of children have limited access to nurturing care. With the Coronavirus disease 2019 (COVID-19) pandemic, it is anticipated that vulnerable children will bear the biggest brunt of the direct and indirect impacts of the pandemic. This review aimed to deepen understanding of the effects of COVID-19 on nurturing care from conception to four years of age, a period where the care of children is often delivered through caregivers or other informal platforms. The review has drawn upon the empirical evidence from previous pandemics and epidemics, and anecdotal and emerging evidence from the ongoing COVID-19 crisis. Multifactorial impacts fall into five key domains: direct health; health and nutrition systems; economic protection; social and child protection; and child development and early learning. The review proposes program and policy strategies to guide the reorientation of nurturing care, prevent the detrimental effects associated with deteriorating nurturing care environments, and support the optimal development of the youngest and most vulnerable children. These include the provision of cash transfers and essential supplies for vulnerable households and strengthening of community-based platforms for nurturing care. Further research on COVID-19 and the ability of children's ecology to provide nurturing care is needed, as is further testing of new ideas.


Subject(s)
Child Development , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Betacoronavirus , COVID-19 , Child , Child Care , Child, Preschool , Humans , Kenya , Pandemics , Policy , SARS-CoV-2
7.
Indian J Med Microbiol ; 38(3 & 4): 461-463, 2020.
Article in English | MEDLINE | ID: covidwho-914617

ABSTRACT

Healthcare worker (HCW) infections due to COVID-19 are of serious consequence. Testing for antibodies against COVID-19 in HCWs has been previously recommended. We conducted a serosurvey in HCWs at a private hospital in Mumbai which is treating COVID patients. A total of 244 HCWs were tested. The prevalence of infection in asymptomatic HCWs was 4.3% and in previously symptomatic untested HCWs was 70%. We recommend that HCWs with a previous history of COVID symptoms who were not tested/tested negative by reverse transcription-polymerase chain reaction should be tested for antibodies at least 2 weeks after onset of symptoms.


Subject(s)
Antibodies, Viral/blood , Betacoronavirus/immunology , Coronavirus Infections/epidemiology , Health Personnel/statistics & numerical data , Pneumonia, Viral/epidemiology , Asymptomatic Diseases/epidemiology , COVID-19 , India/epidemiology , Pandemics , Pilot Projects , Prevalence , Reverse Transcriptase Polymerase Chain Reaction/methods , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL